COMMUNIQUÉS West-GlobeNewswire

Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
23/01/2018
VANCOUVER, British Columbia, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]
Agritek Holdings, Inc. Announces National Feature Interview As Public Cannabis Company On Fox Business Network To Air Nationally January 28th, 2018
23/01/2018
LOS ANGELES, CA, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis [...]
Hemispherx Comments on $500+ Million Market Opportunity for Ampligen®, the Only Late Stage ME/CFS Candidate in the U.S.
23/01/2018
ORLANDO, Fla., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, today commented on the overall market opportunity for its Ampligen ® drug candidate in [...]
Progressive Care Ends Agreement with Boustead Securities
23/01/2018
MIAMI, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
Zealand Pharma to present Phase 2 results on glepaglutide at the ASPEN 2018 Conference in Las Vegas, U.S.
23/01/2018
Company announcement - No. 6/2018 Zealand Pharma to present Phase 2 results on glepaglutide at the ASPEN 2018 Conference in Las Vegas, U.S. Glepaglutide is in development as a potential new treatment for patients with [...]
Avid Bioservices to Present at NobleCon14
23/01/2018
TUSTIN, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]
Quotient Limited to Report Fiscal Third Quarter 2018 Financial Results and Host Conference Call
23/01/2018
JERSEY, Channel Islands, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31 [...]
Hooper Holmes Announces Rebrand to Provant Health
23/01/2018
OLATHE, Kan., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW), the largest publicly-traded, pure-play well-being leader in workplace population health and clinical research support services, today [...]
Akari Therapeutics Strengthens Board with Two Senior Industry Appointments
23/01/2018
NEW YORK and LONDON, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ) (“Akari” or “the Company”), a biopharmaceutical company focused on the development and commercialization of innovative [...]
Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.
23/01/2018
Patent Will Specifically Cover Prophylactic and Post-Exposure Use of NasoShield in the U.S. Patents with Similar Protection Already Issued in Europe and Japan GAITHERSBURG, Md., Jan. 23, 2018 (GLOBE NEWSWIRE) -- [...]
BioCanCell Announces Terms of $25 Million Funding Round
23/01/2018
JERUSALEM, Jan. 23, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ) (the “Company") , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to [...]
Nephros to Present at NobleCon14
23/01/2018
SOUTH ORANGE, N.J., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]
KemPharm Receives Patent Grant for KP606, a Prodrug of Oxycodone
23/01/2018
Additional Patent Granted for the KP511-related family, a Prodrug of Hydromorphone CORALVILLE, Iowa, Jan. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a clinical-stage specialty pharmaceutical company [...]
ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency versus Other Amyloid Beta-Directed Antibodies
23/01/2018
TORONTO and CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN ) (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of precision treatments for [...]
Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease
23/01/2018
CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]
Millennium Blockchain Appoints Michael Terpin to Board of Advisors
23/01/2018
World-renowned blockchain pioneer and communications executive to chair advisory board LAS VEGAS, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain, Inc. (“THCT” or the “Company,”) (OTC:THCT) is pleased to [...]
Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent for the Active Ingredient in Tonmya® (Cyclobenzaprine HCl Sublingual Tablets)
23/01/2018
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent [...]
Helius Medical Technologies Completes Reverse Split of its Class A Common Stock
23/01/2018
NEWTOWN, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]
Transactions in relation to share buyback program
23/01/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Pages